Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
April 16, 1998
Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis
R Y Zee, V S Rao, R Z Paster, et al.
European Journal of Pharmacology
|
December 3, 1981
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats
C S Sweet, P T Arbegast, S L Gaul, et al.
European Journal of Pharmacology
|
February 16, 1988
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction
C S Sweet, C T Ludden, I I Stabilito, et al.
Archives of Internal Medicine
|
February 12, 1996
Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components
J H MacKay, K E Arcuri, A I Goldberg, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
October 1, 1983
Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure
C S Sweet, S L Gaul, P M Reitz, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 18, 2011
A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions
Cara L McDermott, Angela A Hsieh, Erin S Sweet, et al.
Blood Pressure
|
January 1, 1997
Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension
L S Ikeda, S C Harm, K E Arcuri, et al.
Journal of Cardiovascular Pharmacology
|
May 1, 1993
Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal man
J K Doig, R J MacFadyen, C S Sweet, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1984
Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure
C S Sweet, C T Ludden, C M Frederick, et al.
Journal of Human Hypertension
|
November 1, 1995
Losartan potassium as initial therapy in patients with severe hypertension
M C Dunlay, V Fitzpatrick, S Chrysant, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Hypertension (Dallas, Tex. : 1979)
|
April 16, 1998
Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis
R Y Zee, V S Rao, R Z Paster, et al.
European Journal of Pharmacology
|
December 3, 1981
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats
C S Sweet, P T Arbegast, S L Gaul, et al.
European Journal of Pharmacology
|
February 16, 1988
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction
C S Sweet, C T Ludden, I I Stabilito, et al.
Archives of Internal Medicine
|
February 12, 1996
Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components
J H MacKay, K E Arcuri, A I Goldberg, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
October 1, 1983
Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure
C S Sweet, S L Gaul, P M Reitz, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)
|
November 18, 2011
A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions
Cara L McDermott, Angela A Hsieh, Erin S Sweet, et al.
Blood Pressure
|
January 1, 1997
Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension
L S Ikeda, S C Harm, K E Arcuri, et al.
Journal of Cardiovascular Pharmacology
|
May 1, 1993
Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/MK954), in salt-deplete normal man
J K Doig, R J MacFadyen, C S Sweet, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1984
Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure
C S Sweet, C T Ludden, C M Frederick, et al.
Journal of Human Hypertension
|
November 1, 1995
Losartan potassium as initial therapy in patients with severe hypertension
M C Dunlay, V Fitzpatrick, S Chrysant, et al.
Page
of 15